🌐 Entity
Psoriasis
Autoimmune diseases of the skin
📊 Rating
2 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceutical innovation (2)
- Treatment efficacy (1)
- Market impact (1)
- Combination therapy (1)
- Chronic disease treatment (1)
🏷️ Keywords
Taltz (2) · Zepbound (2) · Psoriasis (2) · Eli Lilly (2) · Combination therapy (2) · Clinical trial (1) · Biologic treatment (1) · Pharmaceutical economy (1) · Weight loss (1) · Clinical study (1) · Pharmaceutical innovation (1)
📖 Key Information
Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small localized patches to complete body coverage.
📰 Related News (2)
-
-
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Psoriasis:
-
Eli Lilly · 2 shared articles -
🌐
Ixekizumab · 2 shared articles
-
Tirzepatide · 2 shared articles -
🌐
Combination therapy · 1 shared articles
-
Weight loss · 1 shared articles